Adaptive control in an artificial pancreas for people with type 1 diabetes

被引:54
|
作者
Boiroux, Dimitri [1 ,3 ]
Duun-Henriksen, Anne Katrine [1 ]
Schmidt, Signe [2 ,3 ]
Norgaard, Kirsten [2 ]
Poulsen, Niels Kjolstad [1 ]
Madsen, Henrik [1 ]
Jorgensen, John Bagterp [1 ]
机构
[1] Tech Univ Denmark, Dept Appl Math & Comp Sci, DK-2800 Lyngby, Denmark
[2] Copenhagen Univ Hosp, Dept Endocrinol, DK-2650 Hvidovre, Denmark
[3] Odense Univ Hosp, Danish Diabet Acad, DK-5000 Odense C, Denmark
关键词
Model predictive control; Adaptive control; Artificial pancreas; Type; 1; diabetes; Closed-loop glucose control; MODEL-PREDICTIVE CONTROL; GLUCOSE CONTROL; BIONIC PANCREAS; BETA-CELL; IDENTIFICATION; ADULTS; MPC;
D O I
10.1016/j.conengprac.2016.01.003
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
In this paper, we discuss overnight blood glucose stabilization in patients with type 1 diabetes using a Model Predictive Controller (MPC). We compute the model parameters in the MPC using a simple and systematic method based on a priori available patient information. We describe and compare 3 different model structures. The first model structure is an autoregressive integrated moving average with exogenous input (ARIMAX) structure. The second model structure is an autoregressive moving average with exogenous input (ARMAX) model, i.e. a model without an integrator. The third model structure is an adaptive ARMAX model in which we use a recursive extended least squares (RELS) method to estimate parameters of the stochastic part. In addition, we describe some safety layers in the control algorithm that improve the controller robustness and reduce the risk of hypoglycemia. We test and compare our control strategies using a virtual clinic of 100 randomly generated patients with a representative inter subject variability. This virtual clinic is based on the Hovorka model. We consider the case where only half of the meal bolus is administered at mealtime, and the case where the insulin sensitivity increases during the night. The numerical results suggest that the use of an integrator leads to higher occurrence of hypoglycemia than for the controllers without the integrator. Compared to other control strategies, the adaptive MPC reduces both the time spent in hypoglycemia and the time spent in hyperglycemia. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:332 / 342
页数:11
相关论文
共 50 条
  • [21] An adaptive backstepping based non-linear controller for artificial pancreas in type 1 diabetes patients
    Ahmad, Iftikhar
    Munir, Faysal
    Munir, Muhammad Faizan
    BIOMEDICAL SIGNAL PROCESSING AND CONTROL, 2019, 47 : 49 - 56
  • [22] Artificial pancreas is feasible for pediatric patients with type 1 diabetes
    不详
    Nature Clinical Practice Endocrinology & Metabolism, 2008, 4 (6): : 302 - 302
  • [23] Artificial Pancreas Improved Outcomes in Children With Type 1 Diabetes
    Harris, Emily
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (15): : 1249 - 1249
  • [24] Future Acceptance of an Artificial Pancreas in Adults with Type 1 Diabetes
    van Bon, Arianne C.
    Brouwer, Terry B.
    von Basum, Golo
    Hoekstra, Joost B. L.
    DeVries, J. Hans
    DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (07) : 731 - 736
  • [25] In-Depth Review of Glycemic Control and Glycemic Variability in People with Type 1 Diabetes Using Open Source Artificial Pancreas Systems
    Melmer, Andreas
    Zuger, Thomas
    Lewis, Dana M.
    Leibrand, Scott M.
    Laimer, Markus
    DIABETES, 2019, 68
  • [26] NHS to trial "artificial pancreas" for patients with type 1 diabetes
    Iacobucci, Gareth
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 373 : n1538
  • [27] Artificial pancreas: an emerging approach to treat Type 1 diabetes
    Kumareswaran, Kavita
    Evans, Mark L.
    Hovorka, Roman
    EXPERT REVIEW OF MEDICAL DEVICES, 2009, 6 (04) : 401 - 410
  • [28] Symbolic Control Design of an Artificial Pancreas for Type-2 Diabetes
    Borri, Alessandro
    Pola, Giordano
    Pepe, Pierdomenico
    Di Benedetto, Maria Domenica
    Palumbo, Pasquale
    IEEE TRANSACTIONS ON CONTROL SYSTEMS TECHNOLOGY, 2022, 30 (05) : 2131 - 2146
  • [29] CLINICAL CONTROL OF DIABETES BY ARTIFICIAL PANCREAS
    ALBISSER, AM
    LEIBEL, BS
    EWART, TG
    DAVIDOVAC, Z
    BOTZ, CK
    ZINGG, W
    SCHIPPER, H
    GANDER, R
    DIABETES, 1974, 23 (05) : 397 - 404
  • [30] OPEN ARTIFICIAL PANCREAS SYSTEM REDUCED HYPOGLYCEMIA AND IMPROVED GLYCEMIC CONTROL IN PATIENTS WITH TYPE 1 DIABETES
    Choi, S.
    Hong, E.
    Noh, Y.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A53 - A53